Status:
COMPLETED
Near INfrared Spectroscopy in Aortic valvE ReplacemenT
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Aortic Valve Stenosis
Transcatheter Aortic Valve Implantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transcatheter aortic valve implantation (TAVI) is an alternative for patients, that are considered to be too sick for conventional aortic valve replacement. There is no conclusive opinion about the be...
Eligibility Criteria
Inclusion
- informed consent
- transcatheter aortic valve implantation
Exclusion
- denial by patient
- denial by screening anaesthesist
- active neurodegenerative disease
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01251328
Start Date
December 1 2010
End Date
April 1 2012
Last Update
February 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum München
Munich, Bavaria, Germany, D-80636